Yifan Xinfu Pharmaceutical Co Ltd (002019) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.18 Million ≈ $5.88 Million USD) by net assets (CN¥8.71 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002019 equity financing ratio to measure how much of total assets are equity-financed.
Yifan Xinfu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002019 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Yifan Xinfu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fleury S.A.
SA:FLRY3
|
0.050x |
|
SUEDZUCKER UNSP.ADR 1/2
F:SZU1
|
-0.001x |
|
Worthington Steel Inc
NYSE:WS
|
0.047x |
|
Ducommun Incorporated
NYSE:DCO
|
0.028x |
|
Quantum Computing Inc
NASDAQ:QUBT
|
-0.007x |
|
Anyuan Coal Industry Group Co Ltd
SHG:600397
|
-0.011x |
|
AOZORA BANK LTD ADR/20
F:AON0
|
N/A |
|
Dom Development S.A.
WAR:DOM
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Yifan Xinfu Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.71 Billion ≈ $1.27 Billion |
CN¥458.37 Million ≈ $67.07 Million |
0.053x | -30.80% |
| 2024-12-31 | CN¥8.43 Billion ≈ $1.23 Billion |
CN¥640.73 Million ≈ $93.76 Million |
0.076x | +80.06% |
| 2023-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥348.58 Million ≈ $51.01 Million |
0.042x | -18.18% |
| 2022-12-31 | CN¥9.15 Billion ≈ $1.34 Billion |
CN¥472.07 Million ≈ $69.08 Million |
0.052x | +50.34% |
| 2021-12-31 | CN¥8.78 Billion ≈ $1.28 Billion |
CN¥301.23 Million ≈ $44.08 Million |
0.034x | -73.01% |
| 2020-12-31 | CN¥8.72 Billion ≈ $1.28 Billion |
CN¥1.11 Billion ≈ $162.21 Million |
0.127x | +6.13% |
| 2019-12-31 | CN¥7.82 Billion ≈ $1.14 Billion |
CN¥937.24 Million ≈ $137.15 Million |
0.120x | -29.51% |
| 2018-12-31 | CN¥6.89 Billion ≈ $1.01 Billion |
CN¥1.17 Billion ≈ $171.34 Million |
0.170x | +1.79% |
| 2017-12-31 | CN¥6.78 Billion ≈ $992.46 Million |
CN¥1.13 Billion ≈ $165.75 Million |
0.167x | -23.88% |
| 2016-12-31 | CN¥3.90 Billion ≈ $570.77 Million |
CN¥855.85 Million ≈ $125.24 Million |
0.219x | +57.24% |
| 2015-12-31 | CN¥2.88 Billion ≈ $421.52 Million |
CN¥401.96 Million ≈ $58.82 Million |
0.140x | +154.00% |
| 2014-12-31 | CN¥2.54 Billion ≈ $372.19 Million |
CN¥139.74 Million ≈ $20.45 Million |
0.055x | -38.38% |
| 2013-12-31 | CN¥384.95 Million ≈ $56.33 Million |
CN¥34.32 Million ≈ $5.02 Million |
0.089x | +43.45% |
| 2012-12-31 | CN¥480.81 Million ≈ $70.36 Million |
CN¥29.88 Million ≈ $4.37 Million |
0.062x | +155.24% |
| 2011-12-31 | CN¥469.52 Million ≈ $68.71 Million |
CN¥-52.82 Million ≈ $-7.73 Million |
-0.113x | -134.03% |
| 2010-12-31 | CN¥703.64 Million ≈ $102.96 Million |
CN¥-33.82 Million ≈ $-4.95 Million |
-0.048x | -174.89% |
| 2009-12-31 | CN¥913.15 Million ≈ $133.62 Million |
CN¥58.61 Million ≈ $8.58 Million |
0.064x | -56.02% |
| 2008-12-31 | CN¥570.87 Million ≈ $83.54 Million |
CN¥83.31 Million ≈ $12.19 Million |
0.146x | -67.81% |
| 2007-12-31 | CN¥548.55 Million ≈ $80.27 Million |
CN¥248.71 Million ≈ $36.39 Million |
0.453x | +351.02% |
| 2006-12-31 | CN¥324.46 Million ≈ $47.48 Million |
CN¥32.62 Million ≈ $4.77 Million |
0.101x | +33.73% |
| 2005-12-31 | CN¥320.93 Million ≈ $46.96 Million |
CN¥24.12 Million ≈ $3.53 Million |
0.075x | -30.63% |
| 2004-12-31 | CN¥309.98 Million ≈ $45.36 Million |
CN¥33.59 Million ≈ $4.91 Million |
0.108x | -19.25% |
| 2003-12-31 | CN¥94.31 Million ≈ $13.80 Million |
CN¥12.65 Million ≈ $1.85 Million |
0.134x | -- |
About Yifan Xinfu Pharmaceutical Co Ltd
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more